Loading…
Lobbying Spend
—
Filings
34
Firms Hired
1
Active Period
2003–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Protecting Access to Innovation During COVID–19 Act
2020 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues regarding Medicare Part B covered drugs and devices. Protecting Access to Innovation During COVID-19 Act (H.R. 8624).
Client expense: — · Firm income: —
Matched citations: H.R. 8624
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues regarding prescription drug pricing. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues regarding Medicare Part B covered drugs and devices. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3
Prescription Drug Pricing Reduction Act of 2019
2019 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues regarding prescription drug pricing. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Client expense: — · Firm income: $10,000
Matched citations: S. 2543
Prescription Drug Pricing Reduction Act of 2019
2019 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues regarding Medicare Part B covered drugs and devices. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Client expense: — · Firm income: $10,000
Matched citations: S. 2543
Source: Senate LDA